Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for CRSP

Stock NameCrispr Therapeutics AG
TickerCRSP(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCH0334081137
LEI506700O6IRRIQLT3W370

Show aggregate CRSP holdings

News associated with CRSP

Look Under The Hood: IYY Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-12 08:04:40
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 473 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
Mitsubishi UFJ Asset Management Co. Ltd. raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,725 shares of the company’s stock after buying an additional 473 […] - 2025-08-15 04:46:59
Sum Up The Parts: ESML Could Be Worth $50
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-12 08:44:07
Arkadios Wealth Advisors Has $382,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Arkadios Wealth Advisors decreased its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,238 shares of the company’s stock after selling 923 shares during the period. Arkadios Wealth Advisors’ holdings in CRISPR Therapeutics […] - 2025-08-06 06:46:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Purchased by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 21.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 68,058 shares of the company’s stock after acquiring an additional 12,025 shares during the period. Envestnet […] - 2025-07-29 04:09:03
Bank of New York Mellon Corp Boosts Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
Bank of New York Mellon Corp increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,702 shares of the company’s stock after acquiring an additional 1,133 shares during […] - 2025-07-28 04:22:49
Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Private Advisor Group LLC increased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 27.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,418 shares of the company’s stock after buying an additional 23,382 shares during the quarter. […] - 2025-07-23 06:23:04
3 Monster Stocks in the Making to Buy Right Now
Key PointsCRISPR Therapeutics is still in its early growth stage. - 2025-07-21 01:07:00
3 Monster Stocks to Hold for the Next 10 Years
Key PointsOnline video game platform Roblox is different from any other platform. - 2025-07-17 06:51:00
Allworth Financial LP Has $393,000 Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Allworth Financial LP lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 23.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,560 shares of the company’s stock after selling 3,518 shares during the quarter. Allworth Financial LP’s holdings […] - 2025-07-15 06:16:47
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Lifted by Axxcess Wealth Management LLC
Axxcess Wealth Management LLC increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 10,309 shares of the company’s stock after acquiring an additional 393 shares during the period. Axxcess Wealth Management LLC’s holdings in CRISPR Therapeutics were worth […] - 2025-07-14 05:45:01
Traders Purchase Large Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors bought 10,886 call options on the company. This represents an increase of approximately 49% compared to the typical daily volume of 7,308 call options. CRISPR Therapeutics Trading Down 1.8% NASDAQ CRSP opened at $59.00 on […] - 2025-07-11 02:50:55
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at Needham & Company LLC
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They presently have a $81.00 target price on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 34.82% from the stock’s […] - 2025-07-10 04:01:25
Vontobel Holding Ltd. Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Vontobel Holding Ltd. lessened its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,741 shares of the company’s stock after selling 2,327 shares during the quarter. Vontobel Holding Ltd.’s holdings […] - 2025-07-08 05:21:04
Spire Wealth Management Has $57,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Spire Wealth Management reduced its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,670 shares of the company’s stock after selling 300 shares during the period. Spire Wealth Management’s […] - 2025-07-02 04:46:55
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $69.53 Average Target Price from Analysts
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have issued a buy recommendation on the company. […] - 2025-06-24 02:54:46
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Farther Finance Advisors LLC
Farther Finance Advisors LLC lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 46.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,626 shares of the company’s stock after purchasing an additional 1,792 […] - 2025-06-20 04:29:03
Analysts Expect JHSC To Hit $45
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-10 08:53:42
California State Teachers Retirement System Sells 689 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
California State Teachers Retirement System lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,742 shares of the company’s stock after selling 689 shares during the period. California State […] - 2025-06-06 05:06:55
The Best Stocks to Invest $1,000 in Right Now
Are you just as afraid of a market pullback right now as you are of missing out on upside? If so, you're not alone. This is a confusing environment for investors. Major names like Nvidia and Home Depot are sending mixed messages, while the market itself seems to be waiting for mo - 2025-06-03 05:30:00
Two Sigma Advisers LP Increases Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Two Sigma Advisers LP lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 50.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 84,800 shares of the company’s stock after acquiring an additional 28,400 shares during the period. Two Sigma Advisers LP’s holdings in CRISPR Therapeutics were worth $3,338,000 as of […] - 2025-05-27 05:30:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Moderate Buy” by Analysts
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and ten have assigned a buy recommendation […] - 2025-05-27 03:06:46
Ameriprise Financial Inc. Has $8.07 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Ameriprise Financial Inc. lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 205,173 shares of the company’s stock after acquiring an additional 18,412 shares during the period. Ameriprise Financial Inc.’s holdings in CRISPR Therapeutics were worth $8,072,000 as of its most recent […] - 2025-05-22 04:35:07
5 Monster Stocks to Hold for the Next 10 Years
The professionals who manage Wall Street funds and cater to wealthy investors live and die by their quarterly performance. However, the individual investor can win the long game by focusing on what will matter the most years into the future. - 2025-05-20 05:30:00
BNP Paribas Financial Markets Has $3.27 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
BNP Paribas Financial Markets decreased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,994 shares of the company’s stock after selling 4,962 shares during the quarter. BNP […] - 2025-05-16 05:08:54
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Decreased by Mercer Global Advisors Inc. ADV
Mercer Global Advisors Inc. ADV lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 13.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,980 shares of the company’s stock after selling 1,598 shares during […] - 2025-05-15 05:10:56
Barclays Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $42.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price target lowered by Barclays from $56.00 to $42.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also recently commented on the stock. Truist Financial boosted their price […] - 2025-05-12 05:46:49
3 Monster Stocks to Hold for the Next 10 Years
The best investments are often stocks of companies offering goods and services that are perpetually in demand. Think entertainment, healthcare, or more recently, some consumer technologies. Many of these stocks can be bought and held forever, since they dish out reasonably predic - 2025-05-10 06:12:00
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has momentum on her side. Her largest fund has soared nearly 30% since bottoming out l - 2025-05-08 12:22:00
Dimensional Fund Advisors LP Has $37.28 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Dimensional Fund Advisors LP boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 947,301 shares of the company’s stock after purchasing an additional 122,695 shares during the quarter. Dimensional […] - 2025-05-05 05:20:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) CRSP holdings

DateNumber of CRSP Shares HeldBase Market Value of CRSP SharesLocal Market Value of CRSP SharesChange in CRSP Shares HeldChange in CRSP Base ValueCurrent Price per CRSP Share HeldPrevious Price per CRSP Share Held
2025-11-11 (Tuesday)58,807USD 3,246,734CRSP holding increased by 37048USD 3,246,7340USD 37,048 USD 55.21 USD 54.58
2025-11-10 (Monday)58,807CRSP holding increased by 150USD 3,209,686CRSP holding decreased by -23488USD 3,209,686150USD -23,488 USD 54.58 USD 55.12
2025-11-07 (Friday)58,657USD 3,233,174CRSP holding decreased by -87399USD 3,233,1740USD -87,399 USD 55.12 USD 56.61
2025-11-06 (Thursday)58,657CRSP holding increased by 150USD 3,320,573CRSP holding decreased by -13741USD 3,320,573150USD -13,741 USD 56.61 USD 56.99
2025-11-05 (Wednesday)58,507USD 3,334,314CRSP holding increased by 33934USD 3,334,3140USD 33,934 USD 56.99 USD 56.41
2025-11-04 (Tuesday)58,507CRSP holding increased by 151USD 3,300,380CRSP holding decreased by -315941USD 3,300,380151USD -315,941 USD 56.41 USD 61.97
2025-11-03 (Monday)58,356USD 3,616,321CRSP holding decreased by -117879USD 3,616,3210USD -117,879 USD 61.97 USD 63.99
2025-10-31 (Friday)58,356USD 3,734,200CRSP holding increased by 168648USD 3,734,2000USD 168,648 USD 63.99 USD 61.1
2025-10-30 (Thursday)58,356CRSP holding increased by 755USD 3,565,552CRSP holding decreased by -37967USD 3,565,552755USD -37,967 USD 61.1 USD 62.56
2025-10-29 (Wednesday)57,601CRSP holding increased by 302USD 3,603,519CRSP holding decreased by -73358USD 3,603,519302USD -73,358 USD 62.56 USD 64.17
2025-10-28 (Tuesday)57,299USD 3,676,877CRSP holding decreased by -88813USD 3,676,8770USD -88,813 USD 64.17 USD 65.72
2025-10-27 (Monday)57,299USD 3,765,690CRSP holding decreased by -108295USD 3,765,6900USD -108,295 USD 65.72 USD 67.61
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRSP by Blackrock for IE00BYXG2H39

Show aggregate share trades of CRSP

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY15058.46053.830 54.293USD 8,144 47.80
2025-11-06BUY15058.75054.570 54.988USD 8,248 47.72
2025-11-04BUY15160.64056.000 56.464USD 8,526 47.63
2025-10-30BUY75562.77060.910 61.096USD 46,127 47.40
2025-10-29BUY30262.56065.050 64.801USD 19,570 47.32
2025-10-22SELL-60466.52070.735 70.314USD -42,469 46.81 Loss of -14,198 on sale
2025-10-20BUY30273.97074.430 74.384USD 22,464 46.52
2025-10-17BUY75469.15069.565 69.524USD 52,421 46.39
2025-10-15BUY1,20071.82073.090 72.963USD 87,556 46.25
2025-10-03BUY1,04367.74073.950 73.329USD 76,482 46.00
2025-10-02BUY14972.82072.950 72.937USD 10,868 45.85
2025-09-30BUY29864.81066.290 66.142USD 19,710 45.63
2025-09-26BUY29861.67061.690 61.688USD 18,383 45.43
2025-09-25BUY29860.32061.160 61.076USD 18,201 45.35
2025-09-18BUY14962.94063.100 63.084USD 9,400 45.15
2025-09-17BUY44759.07061.754 61.486USD 27,484 45.07
2025-08-20SELL-59653.07054.370 54.240USD -32,327 44.84 Loss of -5,603 on sale
2025-07-30BUY59657.68061.385 61.014USD 36,365 44.39
2025-07-17SELL-29855.09056.200 56.089USD -16,715 43.24 Loss of -3,829 on sale
2025-07-16BUY49255.14055.330 55.311USD 27,213 43.16
2025-07-11SELL-1,18456.80059.480 59.212USD -70,107 42.91 Loss of -19,298 on sale
2025-07-07BUY44451.19052.877 52.708USD 23,402 42.54
2025-07-02BUY8,14051.67052.285 52.223USD 425,099 42.41
2025-06-20BUY1,52644.25045.140 45.051USD 68,748 42.39
2025-06-11BUY28641.52043.750 43.527USD 12,449 42.39
2025-06-10BUY28642.94045.139 44.919USD 12,847 42.38
2025-06-04SELL-14338.05038.880 38.797USD -5,548 42.45 Profit of 523 on sale
2025-04-23BUY14338.54040.730 40.511USD 5,793 44.05
2025-04-10SELL-1,14434.26034.770 34.719USD -39,719 44.66 Profit of 11,374 on sale
2025-04-08SELL-14331.27035.380 34.969USD -5,001 44.93 Profit of 1,424 on sale
2025-04-07SELL-14332.38034.216 34.032USD -4,867 45.07 Profit of 1,579 on sale
2025-04-04SELL-71532.65032.990 32.956USD -23,564 45.22 Profit of 8,769 on sale
2025-04-01BUY1,26033.14034.930 34.751USD 43,786 45.50
2025-03-31SELL-42334.03035.750 35.578USD -15,049 45.64 Profit of 4,255 on sale
2025-03-21BUY2,03441.22041.680 41.634USD 84,684 46.10
2025-03-14SELL-2,14442.12043.480 43.344USD -92,930 46.40 Profit of 6,551 on sale
2025-03-07SELL-26845.53045.790 45.764USD -12,265 46.63 Profit of 232 on sale
2025-03-04SELL-13443.45044.320 44.233USD -5,927 46.78 Profit of 341 on sale
2025-02-25BUY26844.51046.670 46.454USD 12,450 47.04
2025-02-19SELL-13453.02055.880 55.594USD -7,450 46.86 Loss of -1,171 on sale
2025-02-13BUY40243.49044.140 44.075USD 17,718 46.70
2025-02-12BUY13443.30044.200 44.110USD 5,911 46.77
2025-02-11BUY53639.62039.720 39.710USD 21,285 46.92
2024-12-30SELL-5,05838.65039.670 39.568USD -200,135 49.50 Profit of 50,258 on sale
2024-11-18SELL-2,20547.30048.280 48.182USD -106,241 49.22 Profit of 2,285 on sale
2024-11-08SELL-14751.62052.520 52.430USD -7,707 48.94 Loss of -513 on sale
2024-10-21SELL-14848.51048.940 48.897USD -7,237 0.00 Loss of -7,237 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRSP

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19953,1154,3291,561,11361.1%
2025-09-18785,5858,0691,220,45764.4%
2025-09-17969,1214,9531,279,72475.7%
2025-09-16717,6969,1171,297,12555.3%
2025-09-15563,632479919,63661.3%
2025-09-12474,757434740,27664.1%
2025-09-11514,5242,730952,48454.0%
2025-09-10332,259613508,09265.4%
2025-09-09499,735309750,77466.6%
2025-09-08359,91019,558639,19756.3%
2025-09-05505,8603,4281,468,73234.4%
2025-09-04422,3912821,377,45130.7%
2025-09-03409,382185711,84457.5%
2025-09-02441,840754719,66961.4%
2025-08-29356,0631,032642,32555.4%
2025-08-28384,5934,175619,95962.0%
2025-08-27474,604413707,40967.1%
2025-08-26337,8011,235504,21067.0%
2025-08-25341,566592535,90963.7%
2025-08-22432,3111,060750,30757.6%
2025-08-21276,384525494,43955.9%
2025-08-20481,0352,447863,22655.7%
2025-08-19927,2488,1941,463,44963.4%
2025-08-18615,0979,049934,75965.8%
2025-08-15954,88210,7021,464,72165.2%
2025-08-141,089,3921,0361,635,55366.6%
2025-08-131,486,6797,8272,362,62762.9%
2025-08-12691,84570906,26476.3%
2025-08-11532,8841,847848,36362.8%
2025-08-08465,4267,018715,83465.0%
2025-08-07619,86741,404892,22269.5%
2025-08-06732,61952,4161,122,40965.3%
2025-08-051,326,11768,3261,979,71667.0%
2025-08-04954,1332,8201,308,60572.9%
2025-08-01942,9501,5531,336,17470.6%
2025-07-31761,4542,9451,160,13565.6%
2025-07-30798,1897,6891,224,48365.2%
2025-07-291,040,5228,0251,845,44256.4%
2025-07-28381,2151,024710,36953.7%
2025-07-25712,0351,8071,285,84055.4%
2025-07-24895,7845,5051,297,74669.0%
2025-07-231,105,98171,3881,837,17860.2%
2025-07-221,078,8158,8581,753,95261.5%
2025-07-211,982,72046,3673,377,74658.7%
2025-07-182,862,09113,8775,362,03053.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.